首页> 美国卫生研究院文献>Oncology Letters >Expression of p53 epidermal growth factor receptor Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas
【2h】

Expression of p53 epidermal growth factor receptor Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas

机译:p53表皮生长因子受体Ki-67和O6-甲基鸟嘌呤-DNA甲基转移酶在人脑胶质瘤中的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aimed to evaluate the expression of p53, Ki-67, epidermal growth factor receptor (EGFR) and O6-methylguanine-DNA methyltransferase (MGMT), and to analyze the correlation between their expression and the histological grade of the tumors in 152 patients with gliomas. The tumors were classified according to the recommendations of the World Health Organization (WHO; 2007) into grade I (n=9), grade II (n=56), grade III (n=52) and grade IV (n=35). The expression of p53, Ki-67, EGFR and MGMT was analyzed using immunohistochemistry. The frequency of p53 immunopositivity was significantly lower in grade I gliomas than in grades II, III and IV. The frequency of EGFR immunopositivity was significantly higher in grade III and IV gliomas compared with grades I and II. The mean Ki-67 labelling index (LI) significantly increased in the higher glioma grades. The expression of MGMT in grade I and II tumors was not significantly different from that of grade III and IV tumors. The present data indicate that the expression of EGFR and Ki-67 is significantly correlated with the histological grade of the glioma, but that the expression of p53 and MGMT is not associated with the tumor grade.
机译:本研究旨在评估p53,Ki-67,表皮生长因子受体(EGFR)和O 6 -甲基鸟嘌呤-DNA甲基转移酶(MGMT)的表达,并分析它们之间的相关性。 152例神经胶质瘤患者的肿瘤组织学分级。根据世界卫生组织(WHO; 2007)的建议,将肿瘤分为I级(n = 9),II级(n = 56),III级(n = 52)和IV级(n = 35)。 。使用免疫组织化学分析p53,Ki-67,EGFR和MGMT的表达。 I级神经胶质瘤中p53免疫阳性的频率明显低于II,III和IV级。与I和II级相比,III和IV级神经胶质瘤中EGFR免疫阳性的频率明显更高。在较高的神经胶质瘤等级中,平均Ki-67标记指数(LI)显着增加。 MGMT在I级和II级肿瘤中的表达与III级和IV级肿瘤没有显着差异。目前的数据表明,EGFR和Ki-67的表达与神经胶质瘤的组织学等级显着相关,但p53和MGMT的表达与肿瘤的等级无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号